Market Tracker

03/30 8:23am ET

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

30.75
Delayed Data
As of Mar 29
 -0.10 / -0.32%
Today’s Change
13.92
Today|||52-Week Range
31.43
+21.78%
Year-to-Date
Market Goes on a 'Buy the Dip' Trip
Mar 27 / TheStreet.com - Paid Partner Content
Shark Bites: Even Without Health Care Vote, Market's Feeling Better
Mar 24 / TheStreet.com - Paid Partner Content
There's No Rush for the Exits So Far
Mar 27 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close30.85
Today’s open30.85
Day’s range30.71 - 31.43
Volume456,592
Average volume (3 months)545,715
Market cap$1.5B
Dividend yield--
Data as of 03/29/2017

Growth & Valuation

Earnings growth (last year)+528.57%
Earnings growth (this year)--
Earnings growth (next 5 years)+50.00%
Revenue growth (last year)+48.87%
P/E ratio17.5
Price/Sales6.07
Price/Book8.01

Competitors

 Today’s
change
Today’s
% change
ARRYArray Biopharma Inc-0.19-2.04%
LXRXLexicon Pharmaceutic...+0.53+3.74%
AERIAerie Pharmaceutical...-0.20-0.44%
AXONAxovant Sciences Ltd+0.26+1.77%
Data as of 03/29/2017

Financials

Next reporting dateMay 15, 2017
EPS forecast (this quarter)$0.24
Annual revenue (last year)$215.0M
Annual profit (last year)$91.2M
Net profit margin42.43%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Secretary &
Director
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts